211 related articles for article (PubMed ID: 18949901)
1. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
4. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
[TBL] [Abstract][Full Text] [Related]
6. CSF angiogenin levels in amyotrophic lateral Sclerosis-Frontotemporal dementia spectrum.
Morelli C; Tiloca C; Colombrita C; Zambon A; Soranna D; Lafronza A; Solca F; Carelli L; Poletti B; Doretti A; Verde F; Maderna L; Ticozzi N; Ratti A; Silani V
Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):63-69. PubMed ID: 31852251
[No Abstract] [Full Text] [Related]
7. Immunohistochemical studies of angiogenin in the skin of patients with amyotrophic lateral sclerosis.
Higashida K; Tsukie T; Fukazawa H; Fujikura M; Ono S
J Neurol Sci; 2013 Mar; 326(1-2):18-23. PubMed ID: 23351638
[TBL] [Abstract][Full Text] [Related]
8. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
9. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Dobosz B
Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
[TBL] [Abstract][Full Text] [Related]
11. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
[TBL] [Abstract][Full Text] [Related]
12. [Calcitonin level in cerebrospinal fluid of patients with amyotrophic lateral sclerosis].
Klimek A; Stepień H; Szulc-Kuberska J; Pisarek H
Pol Tyg Lek; 1992 Apr 6-13; 47(14-15):310-1. PubMed ID: 1437739
[TBL] [Abstract][Full Text] [Related]
13. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis.
Greenway MJ; Andersen PM; Russ C; Ennis S; Cashman S; Donaghy C; Patterson V; Swingler R; Kieran D; Prehn J; Morrison KE; Green A; Acharya KR; Brown RH; Hardiman O
Nat Genet; 2006 Apr; 38(4):411-3. PubMed ID: 16501576
[TBL] [Abstract][Full Text] [Related]
14. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
[TBL] [Abstract][Full Text] [Related]
15. CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients.
Moreau C; Gosset P; Brunaud-Danel V; Lassalle P; Degonne B; Destee A; Defebvre L; Devos D
Amyotroph Lateral Scler; 2009 Jun; 10(3):175-81. PubMed ID: 19177252
[TBL] [Abstract][Full Text] [Related]
16. A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy.
Conforti FL; Sprovieri T; Mazzei R; Ungaro C; La Bella V; Tessitore A; Patitucci A; Magariello A; Gabriele AL; Tedeschi G; Simone IL; Majorana G; Valentino P; Condino F; Bono F; Monsurrò MR; Muglia M; Quattrone A
Neuromuscul Disord; 2008 Jan; 18(1):68-70. PubMed ID: 17703939
[TBL] [Abstract][Full Text] [Related]
17. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J
J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650
[TBL] [Abstract][Full Text] [Related]
18. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
19. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
